The Effect of a Mind-body Exercise Program on Aspects of Attention in Individuals With Anxiety
Launched by UNIVERSIDADE FEDERAL DO RIO DE JANEIRO · Apr 5, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special type of exercise that combines the mind and body can help people with anxiety. Researchers want to see if these exercises can improve a person's ability to notice and understand their body's signals, which is important for managing anxiety. Participants will be randomly assigned to either take part in a 15-minute guided meditation session, where they will focus on their breathing and bodily sensations, or to a control group where they will wait in a room without any intervention. After the session, participants will complete some cognitive tests to assess any changes in attention or awareness.
To be eligible for the trial, participants must have a clinical diagnosis of anxiety and be able to understand the study procedures. Unfortunately, those who have Alzheimer's Disease cannot take part. The trial is not yet recruiting participants, but it aims to help individuals learn how mind-body exercises might support their mental health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • clinical diagnosis of anxiety
- • must be able to understand procedures
- Exclusion Criteria:
- • Clinical diagnosis of Alzheimer's Disease
About Universidade Federal Do Rio De Janeiro
The Universidade Federal do Rio de Janeiro (UFRJ) is a prestigious higher education institution located in Brazil, renowned for its commitment to academic excellence and research innovation. As a leading sponsor of clinical trials, UFRJ leverages its extensive resources and multidisciplinary expertise to advance medical knowledge and improve patient outcomes. The university fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring rigorous adherence to ethical standards and regulatory compliance. UFRJ is dedicated to contributing to the global scientific community through the development and implementation of cutting-edge clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported